211 related articles for article (PubMed ID: 21550957)
1. Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study.
Meneghini L; Mersebach H; Kumar S; Svendsen AL; Hermansen K
Endocr Pract; 2011; 17(5):727-36. PubMed ID: 21550957
[TBL] [Abstract][Full Text] [Related]
2. Similar glucose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification.
Malek R; Ajili F; Assaad-Khalil SH; Shinde A; Chen JW; Van den Berg E
Diabetes Metab; 2015 Jun; 41(3):223-30. PubMed ID: 25483023
[TBL] [Abstract][Full Text] [Related]
3. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
[TBL] [Abstract][Full Text] [Related]
4. Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas.
Davies M; Heller S; Sreenan S; Sapin H; Adetunji O; Tahbaz A; Vora J
Diabetes Care; 2013 May; 36(5):1368-76. PubMed ID: 23275363
[TBL] [Abstract][Full Text] [Related]
5. Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial.
Liebl A; Prager R; Binz K; Kaiser M; Bergenstal R; Gallwitz B;
Diabetes Obes Metab; 2009 Jan; 11(1):45-52. PubMed ID: 18643839
[TBL] [Abstract][Full Text] [Related]
6. Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients with type 1 diabetes: a 26-week, phase 3, randomized, open-label, treat-to-target trial.
Hirsch IB; Bode B; Courreges JP; Dykiel P; Franek E; Hermansen K; King A; Mersebach H; Davies M
Diabetes Care; 2012 Nov; 35(11):2174-81. PubMed ID: 22933438
[TBL] [Abstract][Full Text] [Related]
7. Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial.
Rodbard HW; Visco VE; Andersen H; Hiort LC; Shu DH
Lancet Diabetes Endocrinol; 2014 Jan; 2(1):30-7. PubMed ID: 24622667
[TBL] [Abstract][Full Text] [Related]
8. Metabolic control by insulin detemir in basal-bolus therapy: treat-to-target study in children and adolescents with type 1 diabetes.
Nimri R; Lebenthal Y; Shalitin S; Benzaquen H; Demol S; Phillip M
Pediatr Diabetes; 2013 May; 14(3):196-202. PubMed ID: 23289822
[TBL] [Abstract][Full Text] [Related]
9. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
[TBL] [Abstract][Full Text] [Related]
10. Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.
DeVries JH; Bain SC; Rodbard HW; Seufert J; D'Alessio D; Thomsen AB; Zychma M; Rosenstock J;
Diabetes Care; 2012 Jul; 35(7):1446-54. PubMed ID: 22584132
[TBL] [Abstract][Full Text] [Related]
11. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.
Umpierrez GE; Hor T; Smiley D; Temponi A; Umpierrez D; Ceron M; Munoz C; Newton C; Peng L; Baldwin D
J Clin Endocrinol Metab; 2009 Feb; 94(2):564-9. PubMed ID: 19017758
[TBL] [Abstract][Full Text] [Related]
12. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.
Holman RR; Thorne KI; Farmer AJ; Davies MJ; Keenan JF; Paul S; Levy JC;
N Engl J Med; 2007 Oct; 357(17):1716-30. PubMed ID: 17890232
[TBL] [Abstract][Full Text] [Related]
13. Comparison of insulin aspart vs. regular human insulin with or without insulin detemir concerning adipozytokines and metabolic effects in patients with type 2 diabetes mellitus.
Herrmann BL; Kasser C; Keuthage W; Huptas M; Dette H; Klute A
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):210-3. PubMed ID: 23512415
[TBL] [Abstract][Full Text] [Related]
14. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
Yang W; Ji Q; Zhu D; Yang J; Chen L; Liu Z; Yu D; Yan L
Diabetes Care; 2008 May; 31(5):852-6. PubMed ID: 18268073
[TBL] [Abstract][Full Text] [Related]
15. Comparison of once- versus twice-daily administration of insulin detemir, used with mealtime insulin aspart, in basal-bolus therapy for type 1 diabetes: assessment of detemir administration in a progressive treat-to-target trial (ADAPT).
Le Floch JP; Lévy M; Mosnier-Pudar H; Nobels F; Laroche S; Gonbert S; Eschwege E; Fontaine P;
Diabetes Care; 2009 Jan; 32(1):32-7. PubMed ID: 18945928
[TBL] [Abstract][Full Text] [Related]
16. A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus.
Cengiz E; Sherr JL; Erkin-Cakmak A; Weinzimer SA; Burke EN; Sikes KA; Urban AD; Tamborlane WV
Endocr Pract; 2011; 17(6):862-6. PubMed ID: 21550949
[TBL] [Abstract][Full Text] [Related]
17. TREATMENT INTENSIFICATION WITH INSULIN DEGLUDEC/INSULIN ASPART TWICE DAILY: RANDOMIZED STUDY TO COMPARE SIMPLE AND STEP-WISE TITRATION ALGORITHMS.
Gerety G; Bebakar WM; Chaykin L; Ozkaya M; Macura S; Hersløv ML; Behnke T
Endocr Pract; 2016 May; 22(5):546-54. PubMed ID: 26720250
[TBL] [Abstract][Full Text] [Related]
18. Adding fast-acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18-week, open-label, phase 3 trial (onset 3).
Rodbard HW; Tripathy D; Vidrio Velázquez M; Demissie M; Tamer SC; Piletič M
Diabetes Obes Metab; 2017 Oct; 19(10):1389-1396. PubMed ID: 28345792
[TBL] [Abstract][Full Text] [Related]
19. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure.
Davidson MB; Raskin P; Tanenberg RJ; Vlajnic A; Hollander P
Endocr Pract; 2011; 17(3):395-403. PubMed ID: 21324825
[TBL] [Abstract][Full Text] [Related]
20. [Once daily insulin detemir in patients with type 2 diabetes: results of German centers in a 6-month international observational study (SOLVE)].
Liebl A; Wilhelm B; Kaiser M
MMW Fortschr Med; 2012 Dec; 154 Suppl 4():102-9. PubMed ID: 23326928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
